Showing metabocard for N-Acetyl-L-phenylalanine (MMDBc0000521)
| Record Information | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||||||||||||
| Status | Detected and Quantified | ||||||||||||||||||||||
| Creation Date | 2020-12-10 18:39:39 UTC | ||||||||||||||||||||||
| Update Date | 2024-04-30 19:32:46 UTC | ||||||||||||||||||||||
| Metabolite ID | MMDBc0000521 | ||||||||||||||||||||||
| Metabolite Identification | |||||||||||||||||||||||
| Common Name | N-Acetyl-L-phenylalanine | ||||||||||||||||||||||
| Description | N-Acetyl-L-phenylalanine or N-Acetylphenylalanine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-Acetyl-L-phenylalanine can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-Acetyl-L-phenylalanine is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-phenylalanine. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618 ). About 85% of all human proteins and 68% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686 ). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468 ). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468 ). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-acetylphenylalanine can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618 ). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free phenylalanine can also occur. In particular, N-Acetyl-L-phenylalanine can be biosynthesized from L-phenylalanine and acetyl-CoA by the enzyme phenylalanine N-acetyltransferase (EC 2.3.1.53). N-Acetyl-L-phenylalanine is a potential uremic toxin and is considered as a hazardous amphipathic metabolite of phenylalanine (PMID: 4038506 ). Many N-acetylamino acids, including N-acetylphenylalanine, are classified as uremic toxins (PMID: 26317986 ; PMID: 20613759 ). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557 ). N-Acetyl-L-phenylalanine appears in large amount in urine of patients with phenylketonuria (PKU), which is a human genetic disorder due to the lack of phenylalanine hydroxylase, the enzyme necessary to metabolize phenylalanine to tyrosine (PMID: 3473611 ). N-Acetyl-L-phenylalanine is a product of enzyme phenylalanine N-acetyltransferase [EC 2.3.1.53] which is found in the phenylalanine metabolism pathway. N-Acetyl-L-phenylalanine is produced for medical, feed, and nutritional applications such as in the preparation of aspartame. Afalanine (N-Acetyl-DL-phenylalanine) is also approved for use as an antidepressant. | Read more...||||||||||||||||||||||
| Structure |  | ||||||||||||||||||||||
| Synonyms |
| ||||||||||||||||||||||
| Molecular Formula | C11H13NO3 | ||||||||||||||||||||||
| Average Mass | 207.2258 | ||||||||||||||||||||||
| Monoisotopic Mass | 207.089543287 | ||||||||||||||||||||||
| IUPAC Name | (2S)-2-acetamido-3-phenylpropanoic acid | ||||||||||||||||||||||
| Traditional Name | acetyl-L-phenylalanine | ||||||||||||||||||||||
| CAS Registry Number | Not Available | ||||||||||||||||||||||
| SMILES | CC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O | ||||||||||||||||||||||
| InChI Identifier | InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6,10H,7H2,1H3,(H,12,13)(H,14,15)/t10-/m0/s1 | ||||||||||||||||||||||
| InChI Key | CBQJSKKFNMDLON-JTQLQIEISA-N | ||||||||||||||||||||||
| Chemical Taxonomy | |||||||||||||||||||||||
| Functional Ontology | |||||||||||||||||||||||
| Physical Properties | |||||||||||||||||||||||
| Spectra | |||||||||||||||||||||||
| Biological Properties | |||||||||||||||||||||||
| Human Proteins and Enzymes | |||||||||||||||||||||||
| Human Pathways | |||||||||||||||||||||||
| Metabolic Reactions | |||||||||||||||||||||||
| Health Effects and Bioactivity | |||||||||||||||||||||||
| Microbial Sources | |||||||||||||||||||||||
| Exposure Sources | |||||||||||||||||||||||
| Host Biospecimen and Location | |||||||||||||||||||||||
| External Links | |||||||||||||||||||||||
| References | |||||||||||||||||||||||
